Registered number
14503501
Dynami-Therapeutics Limited
Filleted Accounts
30 November 2023
Dynami-Therapeutics Limited
Registered number: 14503501
Balance Sheet
as at 30 November 2023
Notes 2023
£
Fixed assets
Tangible assets 3 19,333
Current assets
Debtors 4 2,138
Cash at bank and in hand 46,422
48,560
Creditors: amounts falling due within one year 5 (16,110)
Net current assets 32,450
Total assets less current liabilities 51,783
Provisions for liabilities (3,800)
Net assets 47,983
Capital and reserves
Called up share capital 100
Profit and loss account 47,883
Shareholder's funds 47,983
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr A Cotterill
Director
Approved by the board on 18 March 2024
Dynami-Therapeutics Limited
Notes to the Accounts
for the year ended 30 November 2023
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Motor vehicles over 5 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
2 Employees 2023
Number
Average number of persons employed by the company 1
3 Tangible fixed assets
Motor vehicles
£
Cost
Additions 20,000
At 30 November 2023 20,000
Depreciation
Charge for the year 667
At 30 November 2023 667
Net book value
At 30 November 2023 19,333
4 Debtors 2023
£
Trade debtors 2,138
5 Creditors: amounts falling due within one year 2023
£
Taxation and social security costs 14,518
Other creditors 1,592
16,110
6 Other information
Dynami-Therapeutics Limited is a private company limited by shares and incorporated in England. Its registered office is:
River Bank House
65A Bishopstoke Road
Bishopstoke
Eastleigh
SO50 6BF
Dynami-Therapeutics Limited 14503501 false 2022-12-01 2023-11-30 2023-11-30 VT Final Accounts October 2023 release 2 Dr A Cotterill No description of principal activity 14503501 2022-12-01 2023-11-30 14503501 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 14503501 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 14503501 bus:Director40 2022-12-01 2023-11-30 14503501 1 2022-12-01 2023-11-30 14503501 2 2022-12-01 2023-11-30 14503501 countries:England 2022-12-01 2023-11-30 14503501 bus:FRS102 2022-12-01 2023-11-30 14503501 bus:FullAccounts 2022-12-01 2023-11-30 14503501 2023-11-30 14503501 core:WithinOneYear 2023-11-30 14503501 core:ShareCapital 2023-11-30 14503501 core:RetainedEarningsAccumulatedLosses 2023-11-30 14503501 2022-11-30 iso4217:GBP xbrli:pure